Behr Jessica, Carnell Lucas R, Stein Rene, Pfister Felix, Friedrich Bernhard, Huber Christian, Lyer Stefan, Band Julia, Schreiber Eveline, Alexiou Christoph, Janko Christina
Department of Otorhinolaryngology, Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung Professorship, Universitätsklinikum Erlangen, 91054 Erlangen, Germany.
Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
Cancers (Basel). 2022 Dec 3;14(23):5978. doi: 10.3390/cancers14235978.
Superparamagnetic iron oxide nanoparticles (SPIONs) are used in nanomedicine as transporter systems for therapeutic cargos, or to magnetize cells to make them magnetically guidable. In cancer treatment, the site-directed delivery of chemotherapeutics or immune effector cells to the tumor can increase the therapeutic efficacy in the target region, and simultaneously reduce toxic side-effects in the rest of the body. To enable the transfer of new methods, such as the nanoparticle-mediated transport from bench to bedside, suitable experimental setups must be developed. In vivo, the SPIONs or SPION-loaded cells must be applied into the blood stream, to finally reach the tumor: consequently, targeting and treatment efficacy should be analyzed under conditions which are as close to in vivo as possible. Here, we established an in vitro method, including tumor spheroids placed in a chamber system under the influence of a magnetic field, and adapted to a peristaltic pump, to mimic the blood flow. This enabled us to analyze the magnetic capture and antitumor effects of magnetically targeted mitoxantrone and immune cells under dynamic conditions. We showed that the magnetic nanoparticle-mediated accumulation increased the anti-tumor effects, and reduced the unspecific distribution of both mitoxantrone and cells. Especially for nanomedical research, investigation of the site-specific targeting of particles, cells or drugs under circulation is important. We conclude that our in vitro setup improves the screening process of nanomedical candidates for cancer treatment.
超顺磁性氧化铁纳米颗粒(SPIONs)在纳米医学中用作治疗性药物的转运系统,或用于使细胞磁化以便对其进行磁引导。在癌症治疗中,将化疗药物或免疫效应细胞定向递送至肿瘤可提高靶区域的治疗效果,同时减少身体其他部位的毒副作用。为了实现新方法的转化,例如将纳米颗粒介导的转运从实验室应用到临床,必须开发合适的实验装置。在体内,必须将SPIONs或负载SPIONs的细胞注入血流,最终到达肿瘤:因此,应在尽可能接近体内的条件下分析靶向性和治疗效果。在此,我们建立了一种体外方法,包括将肿瘤球体置于磁场影响下的腔室系统中,并适配蠕动泵以模拟血流。这使我们能够在动态条件下分析磁性靶向米托蒽醌和免疫细胞的磁捕获及抗肿瘤作用。我们表明,磁性纳米颗粒介导的聚集增强了抗肿瘤作用,并减少了米托蒽醌和细胞的非特异性分布。特别是对于纳米医学研究,研究循环过程中颗粒、细胞或药物的位点特异性靶向很重要。我们得出结论,我们的体外装置改进了用于癌症治疗的纳米医学候选物的筛选过程。